点击图片查看原图

ActiveMax® Recombinant Human Oncostatin M (OSM)

产品价格: ¥7735.00

最小起订量:暂无 可售数量:暂无

发货时限:
暂无
所在地区:
中国北京
有效期至:
长期有效
最后更新:
2021-04-01 01:30:02
浏览次数:
19
企业信息

产品详情

品牌名称:
ACROBiosystems
货号: OSM-H5213
供应商: ACROBiosystems
数量: In Stock
英文名: ActiveMax® Recombinant Human Oncostatin M (OSM)
规格: 50ug
内毒素:
Less than 1.0 EU per μg by the LAL method.

纯度:
>95% as determined by SDS-PAGE.

活性:
The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line). The ED50 for this effect is typically 2-10 ng/mL.

产品背景:
Oncostatin M is also known as OSM, is a glycoprotein belonging to the interleukin-6 family of cytokines that has functions mainly in cell growth. Of these cytokines it most closely resembles leukemia inhibitory factor (LIF) in both structure and function. However, it is as yet poorly defined and is proving important in liver development, haematopoeisis, inflammation and possibly CNS development. It is also associated with bone formation and destruction. OSM signals through cell surface receptors that contain the protein gp130. The type I receptor is composed of gp130 and LIFR, the type II receptor is composed of gp130 and OSMR. Oncostatin M (OSM) was previoustly identified by its ability to inhibit the growth of cells from melanoma and other solid tumors. It also has been reported that OSM, like LIF, IL-6 and G-CSF, has the ability to inhibit the proliferation of murine M1 myeloid leukemic cells and can induce their differentiation into macrophage-like cells. The human form of OSM is insensitive between pH2 and 11 and resistant to heating for one hour at 56 degree but is not stable at 90 degrees. The three dimensional structure of human OSM has been solved to atomic resolution, confirming the predicted long chain four helix bundle topology. Comparing this structure with the known structures of other known LC cytokines shows it to be most closely related to LIF.

产品描述:
ActiveMax® Human Oncostatin M contains no "tag", and has a calculated MW of 25.8 kDa. The predicted N-terminus is Ala 26. The reducing (R) protein migrates as 36 kDa in SDS-PAGE due to glycosylation.
温馨提示:不可用于临床治疗。

免责声明

本网页所展示的有关【ActiveMax® Recombinant Human Oncostatin M (OSM)】的信息/图片/参数等由的会员【北京百普赛斯生物科技有限公司 】提供,由【生物实验采购网】会员【北京百普赛斯生物科技有限公司 】自行对信息/图片/参数等的真实性、准确性和合法性负责,本平台(本网站)仅提供展示服务,请谨慎交易,因交易而产生的法 律关系及法律纠纷由您自行协商解决,本平台(本网站)对此不承担任何责任。您在本网页可以浏览【ActiveMax® Recombinant Human Oncostatin M (OSM)】有关的信息/图片/价格等及提供 【ActiveMax® Recombinant Human Oncostatin M (OSM)】的商家公司简介、联系方式等信息。

在您的合法权益受到侵害时,请您致电,我们将竭诚为您服务,感谢您对【生物实验采购网】的关注与支持!

网站首页 | 关于我们 | 联系方式 | 使用协议 | 版权隐私 | 网站地图  |  排名推广  |  广告服务  |  积分换礼  |  网站留言  |  RSS订阅  |  违规举报
 
免责声明:本站有部分内容来自互联网,如无意中侵犯了某个媒体 、公司 、企业或个人等的知识产权,请来电或致函告之,本网站将在规定时间内给予删除等相关处理。